We are live on
!
Find out more
FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$3.89B
1-Year Est. Return
201.1%
This Fund
S&P 500
This Quarter
Est. Return
+41.63%
1 Year Est. Return
+201.1%
3 Year Est. Return
+879.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.37B
AUM Growth
+$500M
(+27%)
Cap. Flow
+$109M
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
58.56%
Holding
56
New
7
Increased
13
Reduced
6
Closed
6
Top Buys
| 1 |
CG Oncology
CGON
|
+$31.4M |
| 2 |
Oric Pharmaceuticals
ORIC
|
+$23.8M |
| 3 |
BridgeBio Pharma
BBIO
|
+$23.5M |
| 4 |
SLNO
Soleno Therapeutics
SLNO
|
+$18.6M |
| 5 |
PepGen
PEPG
|
+$17.7M |
Top Sells
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$16.1M |
| 2 |
Dyne Therapeutics
DYN
|
+$15.8M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
+$14.1M |
| 4 |
Apogee Therapeutics
APGE
|
+$11.2M |
| 5 |
ETNB
89bio
ETNB
|
+$11.1M |
Sector Composition
| 1 | Healthcare | 99.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
NewAmsterdam Pharma
NAMS
$3.63B
| $289M | 12.2% |
12,226,943
+95,238
| +0.8% | +$1.93M |
|
2
Krystal Biotech
KRYS
$10.1B
| $176M | 7.42% |
988,460
| – | – |
|
3
Mirum Pharmaceuticals
MIRM
$7.16B
| $163M | 6.88% |
6,495,392
| – | – |
|
|
HLVX
4
DELISTED
HilleVax
HLVX
| $163M | 6.86% |
9,781,472
| – | – |
|
|
ALPN
5
DELISTED
Alpine Immune Sciences Inc
ALPN
| $124M | 5.24% |
3,131,008
| – | – |
|
6
Phathom Pharmaceuticals
PHAT
$875M
| $107M | 4.53% |
10,109,279
| – | – |
|
|
7
BridgeBio Pharma
BBIO
$15.7B
| $106M | 4.46% |
3,415,604
+689,655
| +25% | +$23.5M |
|
8
Rhythm Pharmaceuticals
RYTM
$7.28B
| $94.9M | 4% |
2,190,179
-181,125
| -8% | -$7.93M |
|
9
Arcutis Biotherapeutics
ARQT
$3.47B
| $87.1M | 3.67% |
8,785,284
+21,052
| +0.2% | +$157K |
|
10
Vaxcyte
PCVX
$8.09B
| $77.8M | 3.28% |
1,139,405
-25,000
| -2% | -$1.73M |
|
11
Tarsus Pharmaceuticals
TARS
$2.52B
| $65M | 2.74% |
1,787,527
| – | – |
|
12
Edgewise Therapeutics
EWTX
$4.11B
| $60.3M | 2.54% |
3,303,567
+636,364
| +24% | +$10.1M |
|
|
13
Oric Pharmaceuticals
ORIC
$1.11B
| $57M | 2.4% |
4,142,855
+2,000,000
| +93% | +$23.8M |
|
|
APLS
14
DELISTED
Apellis Pharmaceuticals
APLS
| $52M | 2.2% |
885,165
| – | – |
|
15
Disc Medicine
IRON
$2.81B
| $48.9M | 2.06% |
785,000
| – | – |
|
|
VRNA
16
DELISTED
Verona Pharma
VRNA
| $48.5M | 2.05% |
3,014,349
| – | – |
|
|
KALV
17
DELISTED
KalVista Pharmaceuticals
KALV
| $43.7M | 1.85% |
3,687,867
+65,573
| +2% | +$874K |
|
18
Rocket Pharmaceuticals
RCKT
$372M
| $42.1M | 1.77% |
1,561,230
+38,217
| +3% | +$1.09M |
|
|
SLNO
19
DELISTED
Soleno Therapeutics
SLNO
| $37.5M | 1.58% |
875,667
+410,730
| +88% | +$18.6M |
|
20
MacroGenics
MGNX
$262M
| $36.4M | 1.54% |
2,471,704
+70,000
| +3% | +$1.06M |
|
|
JBIO
21
Jade Biosciences
JBIO
$1.25B
| $35.6M | 1.5% |
34,425
| – | – |
|
|
22
CG Oncology
CGON
$6.13B
| $33.8M | 1.43% |
+770,000
| New | +$31.4M |
|
|
MRUS
23
DELISTED
Merus
MRUS
| $33.6M | 1.42% |
746,479
| – | – |
|
24
Revolution Medicines
RVMD
$38.1B
| $32.1M | 1.36% |
997,455
| – | – |
|
|
AUTL
25
Autolus Therapeutics
AUTL
$389M
| $29.5M | 1.24% |
4,623,324
+876,467
| +23% | +$5.47M |
|
Similar funds
GAMH
MSI
CCM
TFM
SCM
MIM
AA
DACG